Acquisition method (AMC)
3
FSC 6505 × MAFENIDE ACETATE CREAM
MAFENIDE ACETATE CREAM
6505-01-561-6429 FSC 6505
NSN 6505-01-561-6429 (also written 6505015616429; NIIN 01-561-6429) is a mafenide acetate cream in Federal Supply Class 6505, Drugs and Biologicals. 5 manufacturer part numbers from 5 suppliers are on record. It was last purchased in Aug 2026.
Open for bid
No open solicitations on record for this NSN right now.
Can you win it?
This item is coded to be bought directly from the actual manufacturer (AMC 3).
Suffix (AMSC)
Z
Competition
Coded for a named source
AMC 3: buy directly from the actual manufacturer, second or later time. AMSC Z: a commercial, nondevelopmental or off-the-shelf item. The codes describe the item's status on record, not any one solicitation. What the codes mean
What it is — can you make it?
Dimensions, the FLIS specification requirements, and the manufacturer part numbers already qualified against this NSN.
Specifications
From the federal catalog (DLA FLIS / PUB LOG) — what your part has to meet. Cited specification documents can be looked up in ASSIST Quick Search ↗, DoD's public spec repository — copy the document number in.
| Requirement | Value |
|---|---|
| SPECIAL FEATURES FEAT | 8.5% MAFENIDE ACTIVE INGREDIENT; NONSTAINING; WATER-VISCIBLE; ANTI-INFECTIVE CREAM FOR TOPICAL ADMINISTRATION TO BURN WOUNDS AND IS INDICATED FOR ADJUNCTIVE THERAPY OF PATIENTS WITH SECOND-AND THIRD-DEGREE BURNS; AVOID EXPOSURE TO EXCESSIVE HEAT (40 DEG.C OR ABOVE); 16 OZ. PLASTIC JAR |
| MEDICAL DESIGNATION AND GRADE MDES | UNITED STATES PHARMACOPEIA |
| ADMINISTRATION CSGS | TOPICAL |
| PART NAME ASSIGNED BY CONTROLLING AGENCY CXCY | MAFENIDE ACETATE CREAM 8.5% SULFAMYLON TOPICAL JAR 16OZ |
| PRIMARY CONTAINER CONTENT QUANTITY CRLK | OUNCES 16.000 |
| ACTIVE INGREDIENT AND STRENGTH CYMG | MAFENIDE PERCENTAGE, W/W 8.500 |
| PRIMARY CONTAINER TYPE CQCT | JAR |
Manufacturer part numbers
Commercial part numbers cross-referenced to this NSN in the federal catalog — the parts that have been accepted as satisfying this stock number, and who makes them.
| Part number | CAGE | Manufacturer |
|---|---|---|
| 6505NCM082410 | 64616 | DEFENSE MEDICAL STANDARDIZATION BOARD |
| 6836 | 89875 | DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA |
| NDC16571-0723-48 | 8FG82 | RISING PHARMA HOLDINGS, INC. DBA RISING PHARMACEUTICALS |
| SULFAMYLON | 65751 | MYLAN INSTITUTIONAL INC |
| SULFAMYLON CREME 453,6G | FB6N1 | INTSEL CHIMOS |
What it pays — so you can quote
The government's own price and demand record for this NSN — what past awards cleared at, so you know where to land your quote.
Latest unit price
—
Purchases
0
Total spend
—
Aug 31, 2026
Last purchased
4 · 4.0/yr
Purchase records
$1,634
Total demand
$326.85
Latest award total
Purchase history
No priced purchases on record for this NSN yet.
Related contract actions
Contract action totals, not unit prices — obligation amounts from USAspending for related awards, shown for context only. These do not appear on the price chart above.
| Action date | Award # | Recipient | Agency | Obligation |
|---|---|---|---|---|
| Aug 31, 2026 | SPE2DX25D9900/SPE2DP26F9397 ↗ | DMS PHARMACEUTICAL GROUP INC | — | $653.70 |
| Aug 31, 2026 | SPE2DX25D9900/SPE2DP26F9370 ↗ | DMS PHARMACEUTICAL GROUP INC | — | $326.85 |
| Aug 31, 2026 | SPE2DX25D9900/SPE2DP26F9369 ↗ | DMS PHARMACEUTICAL GROUP INC | — | $326.85 |
| Aug 31, 2026 | SPE2DX25D9900/SPE2DP26F9368 ↗ | DMS PHARMACEUTICAL GROUP INC | — | $326.85 |
Demand history
Who wins this item
Does one supplier win this every time, and are the winners on the listed-source list? One dot per award.
- Award in the last 2 years
- Older award
DMS PHARMACEUTICAL GROUP INC
last award Aug 2026
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
no award yet
no awards on record
Listed source DEFENSE MEDICAL STANDARDIZATION BOARD
no award yet
no awards on record
Listed source INTSEL CHIMOS
no award yet
no awards on record
Listed source MYLAN INSTITUTIONAL INC
no award yet
no awards on record
Listed source RISING PHARMA HOLDINGS, INC. DBA RISING PHARMACEUTICALS
no award yet
no awards on record
Listed source DMS PHARMACEUTICAL GROUP INC won 4 of the last 4 awards. DMS PHARMACEUTICAL GROUP INC won without being a listed source.
Open RFQs on DIBBS → DIBBS award history ↗
About this data
- Unit prices: DLA DIBBS award records — every row links to its government record.
- AMSC: latest observed value from DIBBS solicitation history as of Oct 28, 2026.
- Contract action totals: USAspending, context only.
- Data last refreshed: 2026-10-27.
- Full methodology →
Cite this page
Citation
NSN Explorer. "MAFENIDE ACETATE CREAM." nsnexplorer.com, https://nsnexplorer.com/nsn/6505-01-561-6429/. Data as of November 7, 2026.
Link
https://nsnexplorer.com/nsn/6505-01-561-6429/